{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:32:27Z","timestamp":1764401547092,"version":"3.38.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.vaccine.2011.01.058","type":"journal-article","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T09:45:40Z","timestamp":1296639940000},"page":"2607-2612","source":"Crossref","is-referenced-by-count":52,"title":["Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO\u00ae, IC51"],"prefix":"10.1016","volume":"29","author":[{"given":"Susanne","family":"Eder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Dubischar-Kastner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Firbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Kaltenboeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Knappik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"Kollaritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Paulke-Korinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Schuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph S.","family":"Klade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.01.058_bib0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis\u2014within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3201\/eid1209.060200","article-title":"Japanese encephalitis outbreak, India, 2005","volume":"12","author":"Parida","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0015","series-title":"Infections of the central nervous system","article-title":"Arthropod-borne viral encephalitides","author":"Solomon","year":"2004"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0020","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0030","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.vaccine.2008.05.081","article-title":"Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 six and 12 month results of a multicenter follow-up phase 3 study","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0035","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.vaccine.2008.12.062","article-title":"Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled phase 3 study","volume":"27","author":"Schuller","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0040","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0045","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.vaccine.2009.10.024","article-title":"Immunogenicity and safety of IXIARO (IC51) in a phase II study in healthy Indian children between 1 and 3 years of age","volume":"28","author":"Kaltenboeck","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0050","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/517323","article-title":"Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects","volume":"176","author":"Liu","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/517358","article-title":"Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules","volume":"177","author":"Tsai","year":"1998","journal-title":"J Infect Dis"},{"year":"2000","series-title":"Statistics with confidence","author":"Altman","key":"10.1016\/j.vaccine.2011.01.058_bib0060"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1708-8305.2007.00134.x","article-title":"Japanese encephalitis for a reference to international travelers","volume":"14","author":"Oya","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0070","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1016\/j.vaccine.2007.01.116","article-title":"Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up","volume":"25","author":"Rendi-Wagner","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0075","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1016\/j.vaccine.2009.09.068","article-title":"Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection","volume":"27","author":"Paulke-Korinek","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0080","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.vaccine.2007.12.015","article-title":"Evaluation of the Langat\/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers","volume":"26","author":"Wright","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0085","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1016\/j.vaccine.2008.08.056","article-title":"Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0090","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/infdis\/171.4.1074","article-title":"Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series","volume":"171","author":"Gambel","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1467-842X.2005.tb00747.x","article-title":"An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait","volume":"29","author":"Hanna","year":"2005","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0100","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.vaccine.2008.01.021","article-title":"A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses","volume":"26","author":"Sohn","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0105","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","article-title":"Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization","volume":"25","author":"Tandan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3201\/eid0601.000103","article-title":"Japanese encephalitis immunization in South Korea: past, present, and future","volume":"6","author":"Sohn","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0115","series-title":"The Australian immunisation handbook","article-title":"Japanese encephalitis","author":"National Health and Medical Research Council","year":"2000"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0120","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1016\/j.vaccine.2010.05.069","article-title":"Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO","volume":"28","author":"Dubischar-Kastner","year":"2010","journal-title":"IC51. Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0125","first-page":"242","article-title":"Global Advisory Committee on vaccine safety, 9\u201310 June 2005","volume":"80","year":"2005","journal-title":"Weekly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.idc.2004.11.004","article-title":"Yellow fever and Japanese encephalitis vaccines: indications and complications","volume":"19","author":"Marfin","year":"2005","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2011.01.058_bib0135","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0140-6736(91)91531-X","article-title":"Adverse reactions to Japanese encephalitis vaccine","volume":"338","author":"Ruff","year":"1991","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11001186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11001186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T09:26:06Z","timestamp":1740907566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11001186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0264410X11001186"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.01.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}